MCP1-Ig fusion variants
    3.
    发明授权
    MCP1-Ig fusion variants 失效
    MCP1-Ig融合变体

    公开(公告)号:US08524217B2

    公开(公告)日:2013-09-03

    申请号:US13105453

    申请日:2011-05-11

    IPC分类号: C07K14/52 A61K38/19

    摘要: The present invention provides, in part, MCP1-Ig fusion polypeptides exhibiting surprisingly beneficial properties as well as methods for treating various diseases (e.g., inflammatory diseases) by administering any of such fusions.

    摘要翻译: 本发明部分地提供了表现出惊人的有益性质的MCP1-Ig融合多肽以及通过施用任何这种融合物来治疗各种疾病(例如炎性疾病)的方法。